Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $208,026 - $386,657
-1,645 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $47,648 - $77,755
211 Added 14.71%
1,645 $418,000
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $115,166 - $251,439
-519 Reduced 26.57%
1,434 $552,000
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $48,196 - $87,177
371 Added 23.45%
1,953 $459,000
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $172,722 - $294,220
1,582 New
1,582 $207,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kcm Investment Advisors LLC Portfolio

Follow Kcm Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.